Sam is an experienced biomedical and life science entrepreneur. He founded the Center for Innovation & Entrepreneurship (CIE Partners) and works closely with clients to develop early-stage concepts into products and businesses. Additionally, he is CEO and founder of Attention Point, a medical software developer of clinical tools for ADHD assessments.
Sam has co-founded and built multiple biomedical/life science companies ranging from diagnostic biochips to pharmaceuticals. As a consultant, he has assisted numerous entrepreneurs to advance their inventions through product development and commercialization. He’s helped start-ups secure approximately $9M of investment.
Sam was the Director of University Relations at the Carilion Biomedical Institute (CBI), a partnership between the University of Virginia, Virginia Tech and the Carilion Clinic. He was responsible for managing the CBI multi-million dollar biomedical research programs at UVA and VT which included seed funding to support proof of concept projects, translational research programs, multi-institutional collaborative R&D projects, tech transfer and startup formation. He also identified, qualified and positioned commercial products from university research performing diligence on more than 70 inventions resulting in 17 patent applications and 6 issued patents. He was responsible for the licensing of 10 technologies that lead to the development of 7 products/business candidates and the launch of 4 start-up companies. These efforts also led to the formation of the Virginia Tech Carilion School of Medicine and Research Institute and the development of Riverside, a research business park in Roanoke.
Additionally, Sam has performed diligence on 12 investment opportunities involving early stage companies for venture capitalists and local angel investors. These resulted in $800K of seed investments into the companies, the relocation of one company to Roanoke, and the launch of 2 start-up companies.
Sam was an Assistant Professor of Chemistry and Coordinator of Interdisciplinary Studies at the Jefferson College of Health Sciences in Roanoke. Before moving to Roanoke, he developed antibiotic-producing microbial strains at Abbott Laboratories in Chicago.
Sam has a PhD in Biochemistry and a BS in Microbiology from Clemson University and completed a post-doc at the University of Missouri. He is an author on more than 15 peer reviewed publications in the area of microbial biochemistry/genetics. He has been a licensing professional in both the Association of University Technology Managers and the Licensing Executives Society.
LinkedIn Profile & Contact Information